TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Evolan Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
637,175
|
492,434
|
486,219 |
Financial expenses |
5,688
|
1,178
|
981 |
Earnings before taxes |
193,127
|
156,285
|
141,740 |
EBITDA |
268,701
|
204,898
|
192,709 |
Total assets |
683,409
|
577,000
|
401,584 |
Current assets |
499,728
|
328,876
|
257,287 |
Current liabilities |
152,879
|
142,833
|
111,300 |
Equity capital |
490,973
|
352,490
|
265,940 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
29
|
27
![]() |
27 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
71.8%
|
61.1%
|
66.2% |
Turnover per employee |
21,972
|
18,238
|
18,008 |
Profit as a percentage of turnover |
30.3%
|
31.7%
|
29.2% |
Return on assets (ROA) |
29.1%
|
27.3%
|
35.5% |
Current ratio |
326.9%
|
230.3%
|
231.2% |
Return on equity (ROE) |
39.3%
|
44.3%
|
53.3% |
Change turnover |
142,206
|
45,599
|
91,087 |
Change turnover % |
29%
|
10%
|
23% |
Chg. No. of employees |
2
|
0
![]() |
0 |
Chg. No. of employees % |
7%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.